The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Smart Nanocarrier Based on PEGylated Hyaluronic Acid for Cancer Therapy
Abstract
Tumor targetability and site-specific drug release of therapeutic nanoparticles are key factors for effective cancer therapy. In this study, poly(ethylene glycol) (PEG)-conjugated hyaluronic acid nanoparticles (P-HA-NPs) were investigated as carriers for anticancer drugs including doxorubicin and camptothecin (CPT). P-HA-NPs were internalized into cancer cells (SCC7 and MDA-MB-231) via receptor-mediated endocytosis, but were rarely taken up by normal fibroblasts (NIH-3T3). During in vitro drug release tests, P-HA-NPs rapidly released drugs when incubated with cancer cells, extracts of tumor tissues, or the enzyme Hyal-1, which is abundant in the intracellular compartments of cancer cells. CPT-loaded P-HA-NPs (CPT-P-HA-NPs) showed dose-dependent cytotoxicity to cancer cells (MDA-MB-231, SCC7, and HCT 116) and significantly lower cytotoxicity against normal fibroblasts (NIH-3T3) than free CPT. Unexpectedly, high concentrations of CPT-P-HA-NPs demonstrated greater cytotoxicity to cancer cells than free CPT. An in vivo biodistribution study indicated that P-HA-NPs selectively accumulated into tumor sites after systemic administration into tumor-bearing mice, primarily due to prolonged circulation in the blood and binding to a receptor (CD44) that was overexpressed on the cancer cells. In addition, when CPT-P-HA-NPs were systemically administrated into tumor-bearing mice, we saw no significant increases in tumor size for at least 35 days, implying high antitumor activity. Overall, P-HA-NPs showed promising potential as a drug carrier for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200250653 · Cited by 1,329
Recent progress in tumor pH targeting nanotechnology
Lee, E. S., Gao, Z., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.003 · Cited by 866
Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action
Stern, R., & Jedrzejas, M. J. (2006) · Chemical Reviews · doi:10.1021/cr050247k · Cited by 804
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Hyaluronan: Preparation, Structure, Properties, and Applications
Lapčík, L., Lapčík, L., De Smedt, S., Demeester, J., & Chabreček, P. (1998) · Chemical Reviews · doi:10.1021/cr941199z · Cited by 737
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
Liu, J.-N., Bu, W., & Shi, J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00525 · Cited by 838
Tian, G., Gu, Z., Zhou, L., Yin, W., Liu, X., Yan, L., Jin, S., Ren, W., Xing, G., Li, S., et al. (2012) · Advanced Materials · doi:10.1002/adma.201104741 · Cited by 827
microRNAs in cancer management
Kong, Y. W., Ferland-McCollough, D., Jackson, T. J., & Bushell, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70073-6 · Cited by 734
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Yoo, J., Park, C., Yi, G., Lee, D., & Koo, H. (2019) · Cancers · doi:10.3390/cancers11050640 · Cited by 726
Nano-selenium and its nanomedicine applications: a critical review
Hosnedlova, B., Kepinska, M., Skalickova, S., Fernandez, C., Ruttkay-Nedecky, B., Peng, Q., Baron, M., Melcova, M., Opatrilova, R., Zidkova, J., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s157541 · Cited by 630
Hyaluronic acid for anticancer drug and nucleic acid delivery
Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.011 · Cited by 596
Deng, X., Cao, M., Zhang, J., Hu, K., Yin, Z., Zhou, Z., Xiao, X., Yang, Y., Sheng, W., Wu, Y., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.006 · Cited by 511
Vasvani, S., Kulkarni, P., & Rawtani, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.066 · Cited by 473
Polysaccharide-based nanoparticles for theranostic nanomedicine
Swierczewska, M., Han, H. S., Kim, K., Park, J. H., & Lee, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.015 · Cited by 415
Self-citationStimuli-responsive polymeric micelles for drug delivery and cancer therapy
Zhou, Q., Zhang, L., Yang, T., & Wu, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s158696 · Cited by 408
Dokukin, M. E., & Sokolov, I. (2012) · Langmuir · doi:10.1021/la302706b · Cited by 385
Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery
Mo, R., & Gu, Z. (2016) · Materials Today · doi:10.1016/j.mattod.2015.11.025 · Cited by 381
Cai, K., He, X., Song, Z., Yin, Q., Zhang, Y., Uckun, F. M., Jiang, C., & Cheng, J. (2015) · Journal of the American Chemical Society · doi:10.1021/ja513034e · Cited by 363
Choi, K. Y., Han, H. S., Lee, E. S., Shin, J. M., Almquist, B. D., Lee, D. S., & Park, J. H. (2019) · Advanced Materials · doi:10.1002/adma.201803549 · Cited by 319
Self-citationPolysaccharide nanoparticles: from fabrication to applications
Plucinski, A., Lyu, Z., & Schmidt, B. V. K. J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00628b · Cited by 308
Treating cancer with microRNA replacement therapy: A literature review
Hosseinahli, N., Aghapour, M., Duijf, P. H. G., & Baradaran, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26514 · Cited by 305
Carbon dots as a trackable drug delivery carrier for localized cancer therapy in vivo
Zeng, Q., Shao, D., He, X., Ren, Z., Ji, W., Shan, C., Qu, S., Li, J., Chen, L., & Li, Q. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01259k · Cited by 289
Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy
Yoon, H. Y., Koo, H., Choi, K. Y., Lee, S. J., Kim, K., Kwon, I. C., Leary, J. F., Park, K., Yuk, S. H., Park, J. H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.016 · Cited by 284
Self-citationTargeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy
Zhi, D., Yang, T., Yang, J., Fu, S., & Zhang, S. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.027 · Cited by 283
Modified hyaluronic acid based materials for biomedical applications
Tiwari, S., & Bahadur, P. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.049 · Cited by 269
Zhu, L., Zhou, Z., Mao, H., & Yang, L. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0316 · Cited by 267
Taiariol, L., Chaix, C., Farre, C., & Moreau, E. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00484 · Cited by 265
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
Kumari, R., Sunil, D., & Ningthoujam, R. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.041 · Cited by 263
Enzyme-Responsive Nanoparticles for Anti-tumor Drug Delivery
Li, M., Zhao, G., Su, W.-K., & Shuai, Q. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00647 · Cited by 253
Beldman, T. J., Senders, M. L., Alaarg, A., Pérez-Medina, C., Tang, J., Zhao, Y., Fay, F., Deichmöller, J., Born, B., Desclos, E., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b01385 · Cited by 196
Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Choi, J.-H., Deng, Z. J., Cho, N.-J., & Hammond, P. T. (2014) · ACS Nano · doi:10.1021/nn502861t · Cited by 179
Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
Choi, K. Y., Silvestre, O. F., Huang, X., Min, K. H., Howard, G. P., Hida, N., Jin, A. J., Carvajal, N., Lee, S. W., Hong, J.-I., et al. (2014) · ACS Nano · doi:10.1021/nn500085k · Cited by 104
Self-citationLi, J., Wei, Y., Zhang, C., Bi, R., Qiu, Y., Li, Y., & Hu, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020621 · Cited by 85
Wu, D., Shi, X., Zhao, F., Chilengue, S. T. F., Deng, L., Dong, A., Kong, D., Wang, W., & Zhang, J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.033 · Cited by 81
Zhu, C., Zhang, H., Li, W., Luo, L., Guo, X., Wang, Z., Kong, F., Li, Q., Yang, J., Du, Y., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.043 · Cited by 53
A photo-controlled hyaluronan-based drug delivery nanosystem for cancer therapy
Sun, F., Zhang, P., Liu, Y., Lu, C., Qiu, Y., Mu, H., & Duan, J. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.11.005 · Cited by 39
Chen, Q., Long, M., Qiu, L., Zhu, M., Li, Z., Qiao, M., Hu, H., Zhao, X., & Chen, D. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s111950 · Cited by 16
Metadata
- Authors
- Choi, K. Y., Yoon, H. Y., Kim, J.-H., Bae, S. M., Park, R.-W., Kang, Y. M., Kim, I.-S., Kwon, I. C., Choi, K., Jeong, S. Y., Kim, K., & Park, J. H.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-10-11
- Volume
- 5
- Issue
- 11
- Pages
- 8591-8599
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2082412592
- Cited by
- 399
- References
- 39
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.